Visual hallucinations in Parkinson’s disease: spotlight on central cholinergic dysfunction - Top-Institutions - MDSpire

Visual hallucinations in Parkinson’s disease: spotlight on central cholinergic dysfunction

By
Anna Ignatavicius
Elie Matar
Simon J G Lewis
September 10, 2024
0 min

Brain

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

#1

University of California, San Francisco (UCSF) Memory and Aging Center

San Francisco, CA
Key Differentiators
- Neurology
- Movement Disorders
- Neurodegeneration
- Neuropharmacology
#2

Mayo Clinic

Rochester, MN
Key Differentiators
- Neurology
- Movement Disorders
- Neurodegenerative Diseases
#3

Johns Hopkins University School of Medicine

Baltimore, MD
Key Differentiators
- Neurology
- Neuropharmacology
- Movement Disorders
#4

King's College London - Institute of Psychiatry, Psychology and Neuroscience (IoPPN)

London, UK
Key Differentiators
- Neurology
- Neuropsychiatry
- Movement Disorders
#5

University of Toronto - Krembil Research Institute

Toronto, ON
Key Differentiators
- Neurology
- Movement Disorders
- Neurodegeneration

Original Source(s)

Brain

Visual hallucinations in Parkinson’s disease: spotlight on central cholinergic dysfunction

by Anna Ignatavicius, Elie Matar, Simon J G Lewis
September 10, 2024

Related Content

Frontiers In Neurology

Commentary: Efficacy and safety of magnetic resonance-guided focused ultrasound for Parkinson's disease: a systematic review and meta-analysis

by Mostafa A. Khalifa
April 30, 2026

Frontiers In Immunology

The Role of Resveratrol in Modulating Neuroinflammation in Alzheimer’s Disease, Parkinson’s Disease, Multiple Sclerosis, and Cerebral Ischemia

by Haoyu Wang, Fei Li, Haifan Wang, Zenan Tian, Hong Fan, Zhibin Shi
April 21, 2026

Frontiers In Endocrinology

The novel GLP-1/GIP dual receptor agonist DA5-CH is superior to tirzepatide and exendin-4 in the 6-OHDA Parkinson rat model